In The Sea Of Biotechs, Anthera's Multi-Drug Pipeline Makes It Attractive By: Benzinga via Benzinga September 17, 2015 at 11:43 AM EDT Anthera Pharmaceuticals Inc (NASDAQ: ANTH) shares are down 5 percent since August 18, remaining below the $10 ... Read More >>